Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:21 PM
Ignite Modification Date:
2025-12-25 @ 9:04 PM
NCT ID:
NCT00804856
Group ID:
EG004
Title:
Phase I Schedule A. Volasertib 300 mg+LDAC
Description:
Volasertib 300 milligram (mg) administered by Intravenous Infusion (IV) over 60 minutes on Days 1 and 15 (28-day cycle) and Low-dose cytarabine (LDAC) 2x20mg per day administered by subcutaneous injection on days 1-10 of each 28 day treatment cycle.
Deaths Number Affected:
9
Deaths Number At Risk:
None
Serious Number Affected:
7
Serious Number At Risk:
9
Other Number Affected:
9
Other Number At Risk:
9
Study:
NCT00804856
Results Section:
NCT00804856
Adverse Events Module:
NCT00804856